# Nicolette

Transforming the Healthcare Experience

## Elevator pitch
We transform data patient data in the electronic health record (EHR) into usable tools that enable the patient to be competent, confident self-advocates. Our first product is called NicoBoard, an empowerment tool for parents of babies in the neonatal intensive care unit (NICU). NicoBoard enables parents to be confident, competent caregivers for their baby in three important ways: data-driven updates and insights, curated education, and participation tools.

- Canonical URL: https://wefunder.com/nicolette
- Entity ID: wefunder:company:92247
- Last updated: 2026-06-22T05:03:23Z
- Generated at: 2026-06-22T20:47:55Z

## Quick facts
- 🚀Mission: Transform healthcare by empowering patients with easy-to-use success tools.
- 🧩Founder Fit: Founded by NICU parents and physicians with deep knowledge of the patient journey.
- 👊Partners: Backed by Backstage Capital, Cedars-Sinai, Techstars, Boomtown, WM360, and more.
- 💥Competitive Advantages: Patent-pending tech, EHR integration, network effects, and first-mover.
- 🎯Execution: First implementation completed with breakthrough results at CHOC Children's Hospital.

## Active fundraises
- wefunder:fundraise:48139: 4(a)(6) successful (USD)
- wefunder:fundraise:48140: 4(a)(6) successful (USD)

## Story
Nicolette empowers patients and their caregivers to be members of their own care team in three ways:Data Transformation: Most patient data is trapped inside a hospital’s electronic health record (EHR) system and is challenging for patients to access. When patients do have access, the data makes little sense. Nicolette’s technology transforms this data into easy-to-understand updates, insights, and visualizations that put everything right in the palm of the patient’s hands.Rapid Education: Receiving a new diagnosis can be a confusing and scary experience. At the same time, finding detailed and complete information regarding the diagnosis is difficult and time consuming. We’ve created an education engine which provides our customers with evidence-based, up-to-date education that is specific to them.Participation Tools: It’s hard to be involved in your own care; we provide tools that prompt patients on when to take action and how to do so. The more engaged the patient, the more likely it is that the best possible outcome will be achieved.These components result in health literacy, which is the greatest tool available to empower patients and their caregivers to self-advocate and be part of their own care team. CEO Phil Martie discusses health literacy here:One of the greatest days of my life was also the worst. It was the first day I got to hold my daughter Nico. It was the only day I got to hold her. Born 15 weeks prematurely and suffering complications, she died at 27 days old. Nico was a twin, whose brother Bex spent 110 days in the neonatal intensive care unit (NICU) before coming home. Throughout our time in the NICU, my wife and I experienced profound helplessness, especially in the tumultuous early going. All around us in the hospital were incredible medical devices, yet there were no tools for us to navigate the journey as parents. We made decisions we would do differently now, signed consent forms we did not understand, and missed opportunities to be hands-on in their care. Most importantly, we could have advocated more effectively for them, but we didn’t know enough or have the confidence to keep pushing where we thought there was an opportunity. Everyone reading this has experienced the same helplessness with their own health or that of someone they love. It’s a big problem because health journeys will not be as successful as possible until patients and their families are treated as partners. At Nicolette, our mission is to transform the healthcare experience for patients by putting them at the center. Patients will be partners with their providers, having the competence to participate in their plan of care and the confidence to take action. The heart of this new experience is data-driven technology that is easy for anyone to use, regardless of tech proficiency or education level. This is the technology we’ve built.We launched this year with a focus on the NICU, and soon will expand to new health applications for young and old alike. Powerful technology built solely for the patient experience will be a standard part of receiving care, and we are passionate about leading that charge. Phil Martie, CEO & Co-founderWhat the Technology Looks LikeHere is a demo of our first product, NicoBoard:The Business ModelWe sell our products to hospitals and insurance companies, billing them a subscription fee of $21 per patient day. Each deal averages hundreds of thousands of dollars annually in recurring revenue, and the gross margin is 80% at scale:Why Would a Hospital or Insurance Company Pay for This?Empowering patients with data-driven technology improves their health outcomes and satisfaction while also reducing costs significantly. It effectively adds a member to the care team for no additional cost and is focused solely on themselves.Our first product, NicoBoard, focuses on the neonatal intensive care unit (NICU), and delivers strong return on investment for hospitals and insurance companies:TractionWe are happy to say that we recently installed NicoBoard for the first time on a 3-year commercial contract at CHOC Children's Hospital. We have an additional pipeline of over 150 hospitals and insurance companies where we are actively engaged in sales at the c-level of the organization. Lastly, we are launching a distribution partnership with Ricoh Corporation, which has a footprint of over 1,000 hospitals in the US and more globally. The Results So FarNicoBoard has now served over 600 families at CHOC's NICU and the results are excellent. Parents are reporting greater input and say in care, receiving more consistent information from the NICU team, and more timely updates on changes in their baby's status. CHOC recently published this research:Next, CHOC will be conducting a proactive study on reduction in length of stay and readmission rates. Our TeamWe are a team of patients, clinicians, and product experts with deep experience in our areas of expertise. Most importantly, we are passionate about empowering patients with success tools. The Investment TermsWe are crowdfunding a minimum of $100,000 to fuel growth to new NICUs and expand our product to new areas.🤝 JOIN US IN TAKING OUR MISSION TO THE NEXT LEVEL 🚀

## FAQ
1. **What are the investment perks?**
   - Good morning, Eli! $250: A very cool Nicolette t-shirt $1,000: A 1:1 Zoom with me! $2,500: Attendance at Nicolette's quarterly conference calls with our management team Early Bird: First $100k committed receives $8m valuation cap. Cap moves to $9.5m after that.
2. **Do you have any future plans to scale this technology to include other health care specialty areas (I.e., oncology, orthopedics)?**
   - Hi Robert! Yes. Our plans to scale focus on adding specialty areas and become a house-wide inpatient / outpatient tool for hospitals. We are already developing our next one now, and will announce it in a few months.
3. **Hello Nicolette Team I hope this finds you well. Based on the populations this app is focused on as well as those this could benefit (ACSC/neurodegenerative) is there a possibility to add an anonymized social support function? For outpatient services will there be a SDoH compo...**
   - Hi Eric, Thanks for the thoughtful questions. Here are some answers for you: 1. Our roadmap DOES include support that uses both peer-to-peer social support and patient-to-expert support, which would include anonymous interactions. 2. SDoH is already a big part of our design process and product. Most NICU parents are low-income families and there many social factors that play in to how well they are able to participate and also their likelihood to be engaged. As we iterate, we are continuing t...
4. **Hi folks - love the concept. Three questions - a) Can you briefly summarize which part of your technology is 'patent pending' ? b) Can you discuss how you do (or plan) to mitigate bias in materials presented to patients making medical decisions (e.g. to ensure balance between ...**
   - Good afternoon, Gemma! Thanks for these excellent questions. Here are some answers for you: A: There are two aspects: 1) transformation of raw data into specific health insights and 2) customized education matching based on patient data. B: The education provided patients/caregivers does not advocate for one intervention or treatment over another, rather it very plainly explains what they are. Education materials are also approved by and tailored to each clinical team, so it is complementary ...
5. **Hi Phil, 1. Can materials on NicoBoard be adjusted according to educational level of the reader? 2. Can multiple NicoBoards access the same information? Such as husband, wife and the grandparents? Do people have to pay multiple times for such accesses? 3. Do you plan to suppor...**
   - Hi John! Thanks for these questions. Here are some answers for you: 1. In a way, it works this way already. The introductory materials that teach the user about a specific topic are written at a 6th-7th grade reading level and contain visuals to speed up and improve comprehension. As users consume these, they are introduced to more complex materials and can consume those if they wish. Here's a real-world example: a premature baby has respiratory distress (RDS) and will be receiving surfactant...

## Team
- Founding Team (Phil, Michel, and Seth)
- Phil Martie (CEO)
- Michel Mikhael (Chief Medical Officer)
- Seth Brickman (Chief Product Officer)
- Tynan Szvetecz (CTO)
- Mindy Morris (Parent Education)

## Recent posts
- Campaign Closing and Other Investment News (2022-01-13T23:29:16Z)
- Nicolette Update Video (2021-12-13T19:55:07Z)
- Startup Thankfulness (2021-11-24T18:28:10Z)
- Cellfie Show Podcast (2021-11-17T18:02:26Z)
- Clinical Research Published on NicoBoard (2021-11-16T00:43:31Z)
- $100k Reached and more updates! (2021-10-12T00:14:53Z)
- Form C Filed! [Action Required] (2021-09-17T21:09:27Z)
- NicoBoard Now Provides Education for Over 700 Diagnoses (2021-08-27T18:49:22Z)
- Second Week Update Message from CEO Phil Martie (2021-08-19T22:56:14Z)
- NicoBoard used by over 400 Families (2021-08-12T15:38:14Z)

## Q&A
- Q: Hi folks - love the concept. Three questions - a) Can you briefly summarize which part of your technology is 'patent pending' ? b) Can you discuss how you do (or plan) to mitigate bias in materials presented to patients making medical decisions (e.g. to ensure balance between information on a surgical option vs. a medication-based one)? c) Can you describe the team building the app (in-house vs. external, size) and whether you intend to keep that structure as the company grows ?
  - A: Good afternoon, Gemma! Thanks for these excellent questions. Here are some answers for you: A: There are two aspects: 1) transformation of raw data into specific health insights and 2) customized education matching based on patient data. B: The education provided patients/caregivers does not advocate for one intervention or treatment over another, rather it very plainly explains what they are. Education materials are also approved by and tailored to each clinical team, so it is complementary to the care being provided. Lastly, the education does not serve as a decision support mechanism; rather, it forms a foundation of knowledge that provides the competence and confidence the patient/family needs to ask better questions, apply critical thinking, and more effectively work with the clinical team. C: Our product team is a blend of in-house and contract team members comprised of five folks. We intend to grow the product team prudently yet aggressively, as there are very powerful new features and products on the roadmap. As we grow, the ratio of in-house will be higher.
- Q: I take it that early bird investors are getting 8M valuations without 20% convertible note and 4% Interest. As it stands now my early investment in Nicolette was at 8M. it does not show that I have 4% interest at 20% discount convertible. Please verify if later investors would be getting better deals than early bird investors.
  - A: Hi Phid, Both notes carry a 4% interest rate and 20% discount. The early bird notes carry the lower cap of $8m, while any investments after the $100k mark will carry a $9.5m cap.
- Q: Hi Phil, 1. Can materials on NicoBoard be adjusted according to educational level of the reader? 2. Can multiple NicoBoards access the same information? Such as husband, wife and the grandparents? Do people have to pay multiple times for such accesses? 3. Do you plan to support languages other than English and Spanish? 4. How is your data security? How do you prevent hacking? Thank you! John Hwung
  - A: Hi John! Thanks for these questions. Here are some answers for you: 1. In a way, it works this way already. The introductory materials that teach the user about a specific topic are written at a 6th-7th grade reading level and contain visuals to speed up and improve comprehension. As users consume these, they are introduced to more complex materials and can consume those if they wish. Here's a real-world example: a premature baby has respiratory distress (RDS) and will be receiving surfactant as a treatment. All parents in this situation receive easy-to-understand content that forms a foundation of knowledge about RDS and empowers them to be active as a member of the team. They also have the option of diving deeper on the topic, e.g. a scholarly research article on surfactant use. Some people choose to dive deeper, and some do not. No matter the case, they all become better informed and have more input and say in care. 2. The health system pays for NicoBoard; there is never any charge to the patient or family. The business model is based on patient days, so the number of log-ins or who is logging in has no impact on the fee. 3. Yes, we have many additional languages on the roadmap. The order in which we roll them out will be driven by how and where we grow first. Having said that, it appears Mandarin will be next. 4. Our cloud infrastructure is HIPAA compliant and connectivity is protected by 256-bit SSL encryption. We employ both monitoring services that detect any unusual activity and penetration testing that specifically aims to penetrate our infrastructure, including the newest hacking methods. We are audited by a HITRUST certified third-party data security firm which issues a report every six months on vulnerabilities and recommended remedies, if any.
- Q: Hello Nicolette Team I hope this finds you well. Based on the populations this app is focused on as well as those this could benefit (ACSC/neurodegenerative) is there a possibility to add an anonymized social support function? For outpatient services will there be a SDoH component, I feel like that could be tremendously beneficial to families? Finally, is utilization of this app billable? Thank you for your time and for the opportunity.
  - A: Hi Eric, Thanks for the thoughtful questions. Here are some answers for you: 1. Our roadmap DOES include support that uses both peer-to-peer social support and patient-to-expert support, which would include anonymous interactions. 2. SDoH is already a big part of our design process and product. Most NICU parents are low-income families and there many social factors that play in to how well they are able to participate and also their likelihood to be engaged. As we iterate, we are continuing to build features that focus on this, and for new products it will be the same. 3. NicoBoard is not billable today, but we are close to our first deal with a payer to reimburse for it. Having said that, health systems receive a healthy ROI even with out billing for the product.
- Q: Do you have any future plans to scale this technology to include other health care specialty areas (I.e., oncology, orthopedics)?
  - A: Hi Robert! Yes. Our plans to scale focus on adding specialty areas and become a house-wide inpatient / outpatient tool for hospitals. We are already developing our next one now, and will announce it in a few months.
- Q: Hi, it’s follow up question regarding note. Any update on missing 4% interest and 20% discount in note? I still don’t see it mentioned in note.
  - A: Hi Rakesh, Here is the answer from Wefunder support: The SPV Subscription Agreement - which is what investors sign - does list the convertible note valuation cap and discount on the last page. It's true that it does not list the interest rate. I think that's just because it's not as major of a term as the cap and discount, and will ultimately not have an enormous impact on the conversion event, so it is left out of the appendix. The investor can always find the full terms listed out in the actual convertible note - here (https://www.sec.gov/Archives/edgar/data/1879104/000167025421001099/document_7.pdf) - or the Form C - here (https://www.sec.gov/Archives/edgar/data/1879104/000167025421001099/document_1.pdf).
- Q: Hi, In one of the response you have said "notes carry a 4% interest rate and 20% discount", but it's no where mentioned in SPV. It's says only about valuation. It would have better if it was clearly mentioned in the last page of SPV along with the valuations.
  - A: Hi Rakesh, I understand! I will ask Wefunder about that and get back to you.
- Q: How did the company name ('Nicolette') come about?
  - A: Good morning, Curtis! We named the company after my daughter, who did not survive her NICU journey. She is one of the two twins I mention in our header video. You can read more about that and the rest of our origin story here: https://health.choc.org/nico-board-a-new-tool-to-empower-choc-nicu-parents/
- Q: What are the investment perks?
  - A: Good morning, Eli! $250: A very cool Nicolette t-shirt $1,000: A 1:1 Zoom with me! $2,500: Attendance at Nicolette's quarterly conference calls with our management team Early Bird: First $100k committed receives $8m valuation cap. Cap moves to $9.5m after that.